Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis
Sandra Kümper1, Faraz K Mardakheh1, Afshan McCarthy1
1Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom.
Abstract:
Rho-associated kinases 1 and 2 (ROCK1/2) are Rho-GTPase effectors that control key aspects of the actin cytoskeleton, but their role in proliferation and cancer initiation or progression is not known. Here, we provide evidence that ROCK1 and ROCK2 act redundantly to maintain actomyosin contractility and cell proliferation and that their loss leads to cell-cycle arrest and cellular senescence. This phenotype arises from down-regulation of the essential cell-cycle proteins CyclinA, CKS1 and CDK1. Accordingly, while the loss of either Rock1 or Rock2 had no negative impact on tumorigenesis in mouse models of non-small cell lung cancer and melanoma, loss of both blocked tumor formation, as no tumors arise in which both Rock1 and Rock2 have been genetically deleted. Our results reveal an indispensable role for ROCK, yet redundant role for isoforms 1 and 2, in cell cycle progression and tumorigenesis, possibly through the maintenance of cellular contractility.
Insights
Rho-associated kinases (ROCK1/2) maintain cell proliferation and actomyosin contractility. Their combined loss halts cell-cycle progression and blocks tumor formation in cancer models.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Rho-associated kinases (ROCK1/2) are key regulators of the actin cytoskeleton.
- Their specific roles in cell proliferation and cancer development remain largely uncharacterized.
Purpose of the Study:
- To investigate the function of ROCK1 and ROCK2 in cell proliferation and tumorigenesis.
- To elucidate the molecular mechanisms underlying ROCK's role in cancer initiation and progression.
Main Methods:
- Utilized mouse models of non-small cell lung cancer and melanoma.
- Performed genetic deletion of Rock1 and Rock2, individually and concurrently.
- Analyzed cell-cycle progression, cellular senescence, and expression of key cell-cycle proteins (CyclinA, CKS1, CDK1).
Main Results:
- ROCK1 and ROCK2 act redundantly to maintain actomyosin contractility and support cell proliferation.
- Loss of both ROCK1 and ROCK2 induces cell-cycle arrest and cellular senescence.
- Down-regulation of CyclinA, CKS1, and CDK1 was observed upon ROCK loss.
- Simultaneous genetic deletion of Rock1 and Rock2 completely inhibited tumor formation in cancer models.
Conclusions:
- ROCK1 and ROCK2 play indispensable, yet redundant, roles in cell cycle progression and tumorigenesis.
- ROCK's function in proliferation and cancer may be mediated through the maintenance of cellular contractility.
- Targeting ROCK isoforms could represent a therapeutic strategy for cancer treatment.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a...
Negative Regulator Molecules
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:


